Live Quote · NASDAQAVIRHealthcare· Biotechnology

Atea Pharmaceuticals, Inc.

$3.96▲ 0.76%(+$0.03)
MKT CAP $318.00MNEXT EARNINGS Mar 4, 2027
50%
Bullish
TickerSpark Score
50/100
▌ Mixed
87
Valuation
20
Profitability
30
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AVIR research report →

Analyst Price Target
$7.00+76.8% vs. today

Range $7 – $7

Analyst RatingHold
1 Buy2 Hold1 Sell

Price Chart

+32.00% · this period
$6.15$4.56$2.97Nov 20May 26Nov 20
52-Week Range29% of range
Low
$2.92
Current
$3.96
High
$6.45